A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

April 30, 2016

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

X0002

Parallel Assignment

DRUG

Placebo

Parallel Assignment

Trial Locations (20)

15009

Heritage Valley Medical Group, Beaver

16635

Altoona Center for Clinical Research, Duncansville

23606

Health Research of Hampton Roads, Inc, Newport News

31904

Columbus Regional Research Institute, Columbus

32720

Clinical Research of South Florida, Coral Gables

Avail Clinical Research, LLC, DeLand

33458

Health Awareness Inc., Jupiter

34652

Suncoast Clinical Research, Inc, New Port Richey

45005

Prestige Clinical Research, LLC, Franklin

45224

Hightop Medical Research, Cincinnati

78209

Quality Research Inc, San Antonio

87106

New Mexico Clinical Research & Osteoporosis Center, Inc., Albuquerque

91978

Encompass Clinical Research, Spring Valley

94598

Diablo Clinical Research, Inc., Walnut Creek

95608

Med Center, Carmichael

85283-1528

Fiel Family & Sports Medicine/Clinical Research Advantage Inc, Tempe

06611

New England Research Assoc., Trumbull

66206-1362

Clinical Trials Technology(CTT) Consultants, Inc., Prairie Village

63042-1755

Healthcare Research Network, Hazelwood

63141-7068

Sundance Clinical Research, LLC, St Louis

All Listed Sponsors
lead

Lina Xu

INDUSTRY

NCT02067611 - A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis | Biotech Hunter | Biotech Hunter